Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/118252
Title: A computationally optimized ribonucleic acid circularization strategy without byproducts
Authors: Chen, R
Zhuang, Y
Zhang, L
Wu, Y
Luo, L
Pan, Y
Li, Y
Zhu, C
Xu, R
Jiang, Y
Hao, Z
Tian, B
Zhang, L
Dong, Y
Liu, D 
Issue Date: 10-Sep-2025
Source: Journal of the American Chemical Society, 10 Sept 2025, v. 147, no. 36, p. 32932-32940
Abstract: Circular mRNA (mRNA) exhibits promising potential in mRNA therapy due to its increased stability and extended duration of protein translation, which has sparked an urgent demand for efficient methods to prepare circular RNAs in vitro. Here, we present a versatile self-circularization strategy that employs simple motifs to synthesize circular RNAs, achieving robust efficiencies for sequences ranging from dozens to thousands of nucleotides. By leveraging an automated computational program, we optimized highly specific lock-key structures to maximize circularization efficiency, particularly for long RNA substrates. Furthermore, the shared sequence and functionality between linear precursor RNAs and circular products eliminate the need for additional purification steps to remove excess nucleic acid components, simplifying the production process. This approach also yields circular RNAs with superior stability and translation efficiency, enabling sustained protein expression in vitro and in vivo. Our computationally optimized, purification-free method holds immense promise for scalable circular RNA production and the development of advanced RNA therapeutics, significantly advancing mRNA therapy.
Publisher: American Chemical Society
Journal: Journal of the American Chemical Society 
ISSN: 0002-7863
EISSN: 1520-5126
DOI: 10.1021/jacs.5c09798
Appears in Collections:Journal/Magazine Article

Open Access Information
Status embargoed access
Embargo End Date 2026-08-28
Access
View full-text via PolyU eLinks SFX Query
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.